Trygg Pharma - M&A Summary and Business Overview

Life ScienceCompany

Trygg Pharma M&A Summary

Trygg Pharma has acquired 1 company. It has also divested 1 asset.

It’s largest disclosed sale occurred in 2013, when it sold Epax AS to FMC for $345M. The Company’s most targeted sectors include life science (100%).

Trygg Pharma Business Overview

Where is Trygg Pharma headquartered?

Trygg Pharma is headquartered in Oslo, Norway.

What sector is Trygg Pharma in?

Trygg Pharma is a life science company.

When was Trygg Pharma founded?

Trygg Pharma was founded in 2009.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

Trygg Pharma

Trygg Pharma Holding AS

Fjordalleen 16,
Oslo, 0250
Norway,
www.tryggpharma.com

Trygg Pharma is a Norwegian-based 50/50 joint venture with Aker BioMarine. TPH is a manufacturer of marine-based omega-3 EPA/DHA concentrates for nutraceutical and pharmaceutical applications. EPAX, TPH’s nutraceutical division, is a long-standing leader in marine-based omega-3 EPA/DHA fatty acid concentrates for nutraceutical manufacturers and marketers, with a focus on the high concentrate segment. Trygg Pharma, TPH’s pharmaceutical division, is completing a Phase III FDA study on an omega-3-based drug candidate for hypertriglyceridemia. Trygg Pharma was founded in 2009 and is based in Oslo, Norway.


M&A Summary

Buy vs Sell

Year '09 '10 '11 '12 '13 T
Buy (0.2/yr) # - 1 - - - 1
Sell (0.2/yr) # - - - - 1 1
vol $345M $345M
  2

Most Recent M&A

Company Date Value Type
Epax AS 2013-07-24 345M USD Divestiture
Oslo, Norway · www.epax.com
Epax AS 2010-09-03 - Divestiture
Oslo, Norway · www.epax.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - 1 (100%) 345M (100%)
Total 1 - 1 $345M

By Geo

State/Country Buy Value Sell Value
Norway 1 - 1 345M
Total 1 - 1 $345M

Deal Values

sell # Total
$100M to $1B 1 $345M
TOTAL $345M
Largest Epax AS
$345M (2013-07-24)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 207,600
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Trygg Pharma

Life Science Companies , Norway Companies